MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
APUS — Apimeds Pharmaceuticals US, Inc.
NYSE AmericanApimeds Pharmaceuticals US, Inc.
$3.22
-0.88(-21.46%)
- O
- 4.10
- H
- 4.16
- L
- 3.10
- V
- 134.55K
⏱️ End-of-day dataAs of Oct 2, 2026
APUS — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | 979,534.00 | $1.64M | $6.99M | $8.74M | 250,342.00 | 3,455.00 |
| Other Short Term Investments | $1.50M | $2.00M | N/A | N/A | N/A | N/A |
| Prepaid Assets | $2.63M | $2.30M | $2.10M | $1.61M | 9,562.00 | 9,602.00 |
| Restricted Cash | $8.00M | $8.00M | N/A | N/A | N/A | N/A |
| Other Current Assets | 48,500.00 | 48,500.00 | N/A | N/A | 9,562.00 | 9,602.00 |
| Total Current Assets | $13.15M | $13.98M | $9.09M | $10.35M | 259,904.00 | 13,057.00 |
| Properties | 228,371.00 | 239,021.00 | 34,188.00 | 13,137.00 | N/A | N/A |
| Investments And Advances | $12.78M | $14.99M | N/A | N/A | N/A | N/A |
| Total Non Current Assets | $12.81M | $15.02M | 163,928.00 | 197,132.00 | 0.00 | 0.00 |
| Total Assets | $14.12M | $16.42M | $9.25M | $10.55M | 259,904.00 | 13,057.00 |
| Accrued Expenses | $1.01M | 527,952.00 | 25,308.00 | 25,257.00 | 117,899.00 | 106,643.00 |
| Short Term Debt | $9.41M | $7.63M | 500,000.00 | 500,000.00 | 623,620.00 | 250,000.00 |
| Pensions | 13,000.00 | N/A | 18,250.00 | 8,250.00 | 287,050.00 | 180,550.00 |
| Other Current Liabilities | $1.57M | $1.62M | N/A | 174,413.00 | N/A | N/A |
| Total Current Liabilities | $14.58M | $10.71M | $1.09M | 809,002.00 | $1.77M | $1.02M |
| Long Term Debt | 118,815.00 | 129,454.00 | N/A | N/A | 250,000.00 | 346,844.00 |
| Total Non Current Liabilities | 118,815.00 | 129,454.00 | 0.00 | 0.00 | 250,000.00 | 346,844.00 |
| Total Liabilities | $14.70M | $10.84M | $1.09M | 809,002.00 | $2.02M | $1.37M |
| Common Stock | 125,760.00 | 125,760.00 | 125,760.00 | 125,760.00 | 79,039.00 | 79,039.00 |
| Retained Earnings | $-45.45M | $-10.39M | $-9.24M | $-7.46M | $-4.79M | $-4.39M |
| Total Shareholders Equity | $12.65M | $15.33M | $8.16M | $9.74M | $-1.76M | $-1.36M |
| Additional Paid In Capital | $16.37M | $16.35M | $17.27M | $17.07M | $2.95M | $2.95M |
| Cash | N/A | $1.64M | $6.99M | $8.74M | 250,342.00 | 3,455.00 |
| Accounts Payable | N/A | 918,649.00 | N/A | N/A | N/A | N/A |